CLINICAL_TRIALS
research
· 2024-07-09
Clinical Trial Update: Cerebrolysin as an Add-On Therapy to Standard Treatment of Basilar Artery Occlusion [EARLY_Phase 1]
Summary
Cerebrolysin is being studied as an add-on therapy to standard treatment for basilar artery occlusion in an early phase 1 trial; the study is not yet recruiting…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Hospital Sestre Milosrdnice | Conditions: Basilar Artery Occlusion, Posterior Circulation Brain Infarction | EARLY_Phase 1 | Status: NOT_YET_RECRUITING